176 related articles for article (PubMed ID: 33416165)
1. Expression and role of fibroblast activation protein α in acute myeloid leukemia.
Mei S; Zhang Y; Yu L; Chen G; Zi F
Oncol Rep; 2021 Feb; 45(2):641-651. PubMed ID: 33416165
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway.
Zi FM; He JS; Li Y; Wu C; Wu WJ; Yang Y; Wang LJ; He DH; Yang L; Zhao Y; Zheng GF; Han XY; Huang H; Yi Q; Cai Z
Cancer Biol Ther; 2014 Oct; 15(10):1413-22. PubMed ID: 25046247
[TBL] [Abstract][Full Text] [Related]
3. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
Liang X; Xia R
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
5. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
Xiao Y; Deng T; Ming X; Xu J
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
[TBL] [Abstract][Full Text] [Related]
6. Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.
Zeng Z; Shi YX; Tsao T; Qiu Y; Kornblau SM; Baggerly KA; Liu W; Jessen K; Liu Y; Kantarjian H; Rommel C; Fruman DA; Andreeff M; Konopleva M
Blood; 2012 Sep; 120(13):2679-89. PubMed ID: 22826565
[TBL] [Abstract][Full Text] [Related]
7. Targeting FAPα-expressing tumor-associated mesenchymal stromal cells inhibits triple-negative breast cancer pulmonary metastasis.
Li X; Chen M; Lu W; Tang J; Deng L; Wen Q; Huang M; Deng R; Ye G; Ye W; Zhang D
Cancer Lett; 2021 Apr; 503():32-42. PubMed ID: 33482262
[TBL] [Abstract][Full Text] [Related]
8. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
9. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
[TBL] [Abstract][Full Text] [Related]
10. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.
Zhai H; Zhao J; Pu J; Zhao P; Wei J
Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643
[TBL] [Abstract][Full Text] [Related]
11. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
[TBL] [Abstract][Full Text] [Related]
12. CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt/β-catenin signaling pathway.
Ji H; Chen L; Xing Y; Li S; Dai J; Zhao P; Wang Y
Pediatr Res; 2019 Jun; 85(7):1024-1031. PubMed ID: 30862962
[TBL] [Abstract][Full Text] [Related]
13. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
[TBL] [Abstract][Full Text] [Related]
14. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
Chen L; Hu N; Wang C; Zhao H
Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
[TBL] [Abstract][Full Text] [Related]
15. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway.
Xin H; Li C; Wang M
Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor 15 contributes to cancer-associated fibroblasts-mediated chemo-protection of AML cells.
Zhai Y; Zhang J; Wang H; Lu W; Liu S; Yu Y; Weng W; Ding Z; Zhu Q; Shi J
J Exp Clin Cancer Res; 2016 Sep; 35(1):147. PubMed ID: 27643489
[TBL] [Abstract][Full Text] [Related]
17. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
[No Abstract] [Full Text] [Related]
18. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
Li C; Xin H; Shi Y; Mu J
Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
[TBL] [Abstract][Full Text] [Related]
19. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
20. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
Wang Y; Tong H; Wang J; Hu L; Huang Z
J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
